1naresh

Array
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)
1nareshArray
(
    [urn:ac.highwire.org:guest:identity] => Array
        (
            [runtime-id] => urn:ac.highwire.org:guest:identity
            [type] => guest
            [service-id] => ajnr-ac.highwire.org
            [access-type] => Controlled
            [privilege] => Array
                (
                    [urn:ac.highwire.org:guest:privilege] => Array
                        (
                            [runtime-id] => urn:ac.highwire.org:guest:privilege
                            [type] => privilege-set
                            [privilege-set] => GUEST
                        )

                )

            [credentials] => Array
                (
                    [method] => guest
                )

        )

)

Table 1: Demographic and clinical data
No. Age (yr) Sex Histology Level Dose (Gy) Fractions Response
1 57 F Renal cell carcinoma L1 24 1 OPP
3 55 M Renal cell carcinoma L4 24 1 SD
4 54 F Renal cell carcinoma T12 24 1 PD
5 52 M Renal cell carcinoma L1 27 3 PR
8 52 M Renal cell carcinoma L4 30 5 PD
9 42 M Renal cell carcinoma T11 30 5 SD
11 53 F Renal cell carcinoma T12 30 5 PR
12 60 F Breast carcinoma T8 30 5 SD
13 63 F Melanoma L1 27 3 SD
15 58 M Basal cell carcinoma T4 30 5 PD
16 32 F Thyroid carcinoma L3 30 5 SD
17 46 F Thyroid carcinoma L1 27 3 PR
L2 27 3 SD
18 50 F Thyroid carcinoma T11 27 3 SD
19 49 M Thyroid carcinoma T6 27 3 PD
20 44 F Sarcoma C3 27 3 PR
22 50 F Sarcoma T8 27 3 SD
23 70 F Sarcoma L2 27 3 PR
24 49 M Thyroid carcinoma T1 27 3 SD
25 48 F Breast carcinoma T2 18 1 PR
26 51 F Breast carcinoma T5 18 1 SD
27 38 F Lung carcinoma L1 18 1 SD
29 74 M Lung carcinoma L1 18 1 OPP
30 35 M Sarcoma T8 16 1 PR
31 50 F Sarcoma T5 18 1 PD
32 59 M Sarcoma T5 18 1 SD
35 44 M Renal cell carcinoma L4 24 1 PD
36 63 M Renal cell carcinoma L6 24 1 OPP
37 70 M Renal cell carcinoma T12 24 1 OPP
38 65 M Renal cell carcinoma C3 24 1 PR
39 61 M Renal cell carcinoma T6 27 3 PD
40 33 F Breast carcinoma L4 27 3 PD
41 67 M Colon carcinoma L3 27 3 PR
42 48 F Adenoid cystic carcinoma C2 27 3 PD
43 58 F Thyroid carcinoma L2 27 3 PR
44 34 F Breast carcinoma T9 16 1 PR
45 65 M Prostate carcinoma T6 16 1 OPP
Note:—SD indicates stable disease.